West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
331.04
-5.99 (-1.78%)
Feb 4, 2025, 4:00 PM EST - Market closed
WST Revenue
West Pharmaceutical Services had revenue of $746.90M in the quarter ending September 30, 2024, a decrease of -0.07%. This brings the company's revenue in the last twelve months to $2.88B, down -1.71% year-over-year. In the year 2023, West Pharmaceutical Services had annual revenue of $2.95B with 2.18% growth.
Revenue (ttm)
$2.88B
Revenue Growth
-1.71%
P/S Ratio
8.44
Revenue / Employee
$271,358
Employees
10,600
Market Cap
23.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
Dec 31, 2019 | 1.84B | 122.50M | 7.13% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 63.17B |
AbbVie | 56.33B |
Novartis AG | 51.72B |
AstraZeneca | 51.21B |
Thermo Fisher Scientific | 42.88B |
Abbott Laboratories | 41.95B |
WST News
- 5 days ago - West to Host Fourth-Quarter and Full-Year 2024 Conference Call - PRNewsWire
- 7 days ago - West Announces First-Quarter Dividend - PRNewsWire
- 13 days ago - West Introduces Daikyo PLASCAP® RUV Closures in New Nested Format at Pharmapack - PRNewsWire
- 22 days ago - Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth - Seeking Alpha
- 4 weeks ago - West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference - PRNewsWire
- 7 weeks ago - West Elects New Director to the Board - PRNewsWire
- 2 months ago - 3 Dividend Gems You Didn't Know Could Build Lasting Wealth - Seeking Alpha
- 3 months ago - 17 Upcoming Dividend Increases - Seeking Alpha